|
시장보고서
상품코드
2078193
신경혈관 기기 시장 : 기기 유형별, 치료 용도별, 최종사용자별, 지역별Neurovascular Devices Market, By Device Type, By Therapeutic Application, By End User, By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
신경혈관 기기 시장은 2026년에 29억 8,000만 달러, 2033년까지 40억 1,000만 달러에 이를 것으로 예상됩니다. 또한, 2026-2033년 CAGR 4.3%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 29억 8,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 4.30% | 2033년 시장 규모 예측 : | 40억 1,000만 달러 |
신경혈관/중재적 신경학용 의료기기란, 뇌동맥류나 신경혈관 혈전 제거술 등 신경혈관 질환의 치료에 사용되는 코일, 스텐트, 혈전 제거 기기 및 기타 기기를 말합니다. 혈전 제거술, 흡입 장치 및 흡입 기구는 뇌의 동맥이나 정맥에서 혈전을 제거하는 데 사용되며, 이러한 혈전은 뇌졸중의 원인이 되기도 합니다. 신경혈관용 의료기기는 산소를 운반하는 혈액을 뇌의 각 부위로 전달하는 혈관과 관련된 질환의 치료에 사용됩니다.
시장 역학
규제 당국의 제품 승인 등 유기적 성장 전략의 확대가 예측 기간 동안 시장 성장을 견인할 것으로 전망됩니다. 예를 들어, 2020년 7월, 비상장 상태이며 상용화 단계에 있는 의료기기 기업인 Cerus Endovascular Ltd.는 의사가 구부러진 신경혈관계에 접근하여 치료용 기기를 지정된 표적 부위에 전달할 수 있도록 설계된 최첨단 마이크로카테터 ‘ CerusEndo MC 021”에 대해, Conformite Europeenne(CE) 마크 승인을 획득했다고 발표했습니다. “CerusEndo MC 021”마이크로카테터는 원위부의 유연한 프로파일이 여러 가지로 제공되며, 우수한 근위부 지지 기능을 갖추고 있어 의사의 손끝에서 삽입 및 조작성이 향상됩니다.
주요 시장 참여자들이 제품 포트폴리오 확대를 위한 계약 등 비유기적 성장 전략을 늘려감에 따라, 예측 기간 동안 시장 성장을 견인할 것으로 예측됩니다. 예를 들어, 2020년 8월, 비상장 기업이자 상용화 단계에 있는 의료기기 기업인 Cerus Endovascular Ltd.는 Balt의 완전 자회사인 AB Medica Deutschland Verwaltungs GmbH와 판매 계약을 체결했다고 발표했습니다. 이 계약에 따라 AB Medica Deutschland Verwaltungs GmbH는 새로 유럽 적합성(CE) 마크를 획득한 “Contour Neurovascular System” 및 “Neqstent Coil Assisted Flow Diverter” 기기를 독일 내에서 독점적으로 판매할 권리를 획득했습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문에서 잠재적인 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 신경혈관 기기 시장의 주요 기업 프로파일을 소개했습니다.
- 본 조사에서 다룬 주요 기업으로는 Medtronic Plc, Koninklijke Philips N.V., Abbott, Johnson &Johnson Service Inc., Merit Medical Systems, Inc., Stryker, Penumbra, Inc., Acandis GmbH & Co. KG, MicroPort Scientific Corporation, Terumo Corporation, Cerus Endovascular Limited, ASAHI INTECC USA, INC., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., iVascular, LifeHealthcare, Veiva 및 Nordson MEDICAL이 포함됩니다.
- 본 보고서의 인사이트를 활용함으로써, 각 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 세계의 신경혈관 기기 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 신경혈관용 기기 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 신경혈관 기기 시장 : 기기 유형별, 2021년-2033년
제5장 세계의 신경혈관 기기 시장 : 치료 용도별, 2021년-2033년
제6장 세계의 신경혈관 기기 시장 : 최종사용자별, 2021년-2033년
제7장 세계의 신경혈관 기기 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 섹션
LSH 26.07.10Neurovascular Devices Market is estimated to be valued at USD 2.98 Bn in 2026 and is expected to reach USD 4.01 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.98 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.30% | 2033 Value Projection: | USD 4.01 Bn |
Neurovascular/interventional neurological devices are devices that include coils, stents, thrombectomy devices, and other devices used to treat neurovascular diseases such as cerebral aneurysms and neurovascular thrombectomies. Thrombectomies, suction devices, and aspiration devices are used to remove blood clots from the arteries and veins of the brain, which can also cause strokes. Neurovascular devices are used to treat disorders associated with blood vessels that carry oxygenated blood to brain areas.
Market Dynamics
Increasing organic growth strategies such as product approvals by regulatory authorities are expected to drive the market growth over the forecast period. For instance, in July 2020, Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, announced that it has received Conformite Europeenne (CE) Mark approval for its state-of-the-art CerusEndo MC 021 microcatheter, designed to allow physicians to access tortuous neurovasculature and deliver therapeutic devices to intended target. The CerusEndo MC 021 microcatheter is available in multiple distal flexible profiles and offers superior proximal support, which translates to enhanced deliverability and responsiveness in physicians' hands.
Increasing inorganic growth strategies, such as agreements, by key market players to expand their product portfolios is expected to drive the market growth over the forecast period. For instance, in August 2020, Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company announced a distribution agreement with AB Medica Deutschland Verwaltungs GmbH, a wholly-owned subsidiary of Balt, to provide AB Medica Deutschland Verwaltungs GmbH with the exclusive rights to market and sell the newly Conformite Europeenne (CE) marked Contour Neurovascular System and the Neqstent Coil Assisted Flow Diverter devices in Germany.
Key features of the study:
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global neurovascular devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Medtronic Plc, Koninklijke Philips N.V., Abbott, Johnson & Johnson Service Inc., Merit Medical Systems, Inc., Stryker, Penumbra, Inc., Acandis GmbH & Co. KG, MicroPort Scientific Corporation, Terumo Corporation, Cerus Endovascular Limited., ASAHI INTECC USA, INC., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., iVascular, LifeHealthcare, Veiva, and Nordson MEDICAL
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global neurovascular devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurovascular devices market
Detailed Segmentation:
- Global Neurovascular Devices Market, By Device Type (Revenue, USD Bn, 2021 - 2033):
- Embolization Coils
- Platinum Coils
- Coated Platinum Coils
- Liquid Embolic Coils
- Neurovascular Stents
- Carotid Artery Stents
- Flow Diversion Stents
- Neurothrombectomy Devices
- Clot Retrievers, Aspiration
- Suction Devices
- Vascular Snares
- Embolic Protection Devices
- Distal Filter Devices
- Balloon Occlusion Devices
- Neurovascular Supporting Devices
- Microcatheters
- Microguidewire
- Global Neurovascular Devices Market, By Therapeutic Application (Revenue, USD Bn, 2021 - 2033):
- Cerebral Aneurysms
- Ischemic Stroke
- Cerebral Artery Stenosis
- Arteriovenous Malformations (AVMs)
- AV Fistulas
- Others
- Global Neurovascular Devices Market, By End User (Revenue, USD Bn, 2021 - 2033):
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
- Global Neurovascular Devices Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Medtronic Plc
- Koninklijke Philips N.V.
- Abbott
- Johnson & Johnson Service Inc.
- Merit Medical Systems, Inc.
- Stryker
- Penumbra, Inc.
- Acandis GmbH & Co. KG
- MicroPort Scientific Corporation
- Terumo Corporation
- Cerus Endovascular Limited.
- ASAHI INTECC USA, INC.
- ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
- iVascular
- LifeHealthcare
- Veiva
- Nordson MEDICAL
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Device Type
- Market Snapshot, By Therapeutic Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Partnership Scenario
- Brand and Pricing Analysis
- Distributors Landscape
- Porters Analysis
- Technological Advancements
- Key Developments
- Market Trend
4. Global Neurovascular Devices Market, By Device Type, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Embolization Coils
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Platinum Coils
- Coated Platinum Coils
- Liquid Embolic Coils
- Neurovascular Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Carotid Artery Stents
- Flow Diversion Stents
- Neurothrombectomy Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Clot Retrievers
- Aspiration/Suction Devices
- Vascular Snares
- Embolic Protection Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Distal Filter Devices
- Balloon Occlusion Devices
- Neurovascular Supporting Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Microcatheters
- Microguidewires
5. Global Neurovascular Devices Market, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Cerebral Aneurysms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Ischemic Stroke
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Cerebral Artery Stenosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Arteriovenous Malformations (AVMs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- AV Fistulas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
6. Global Neurovascular Devices Market, By End User, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
7. Global Neurovascular Devices Market By Region, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2021 - 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Medtronic Plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson Service Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merit Medical Systems, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Stryker
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Penumbra, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Acandis GmbH & Co. KG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- MicroPort Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cerus Endovascular Limited.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ASAHI INTECC USA, INC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- iVascular
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LifeHealthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Veiva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nordson MEDICAL
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
